2NAW | pdb_00002naw

NMR solution structure of Exendin-4/conotoxin chimera (Ex-4[1-27]/pl14a)


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 50 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with the lowest energy 

wwPDB Validation 3D Report Full Report

Validation slider image for 2NAW

This is version 1.5 of the entry. See complete history

Literature

Truncated Glucagon-like Peptide-1 and Exendin-4 alpha-Conotoxin pl14a Peptide Chimeras Maintain Potency and alpha-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro.

Swedberg, J.E.Schroeder, C.I.Mitchell, J.M.Fairlie, D.P.Edmonds, D.J.Griffith, D.A.Ruggeri, R.B.Derksen, D.R.Loria, P.M.Price, D.A.Liras, S.Craik, D.J.

(2016) J Biological Chem 291: 15778-15787

  • DOI: https://doi.org/10.1074/jbc.M116.724542
  • Primary Citation Related Structures: 
    2NAV, 2NAW

  • PubMed Abstract: 

    Glucagon-like peptide-1 (GLP-1) signaling through the glucagon-like peptide 1 receptor (GLP-1R) is a key regulator of normal glucose metabolism, and exogenous GLP-1R agonist therapy is a promising avenue for the treatment of type 2 diabetes mellitus. To date, the development of therapeutic GLP-1R agonists has focused on producing drugs with an extended serum half-life. This has been achieved by engineering synthetic analogs of GLP-1 or the more stable exogenous GLP-1R agonist exendin-4 (Ex-4). These synthetic peptide hormones share the overall structure of GLP-1 and Ex-4, with a C-terminal helical segment and a flexible N-terminal tail. Although numerous studies have investigated the molecular determinants underpinning GLP-1 and Ex-4 binding and signaling through the GLP-1R, these have primarily focused on the length and composition of the N-terminal tail or on how to modulate the helicity of the full-length peptides. Here, we investigate the effect of C-terminal truncation in GLP-1 and Ex-4 on the cAMP pathway. To ensure helical C-terminal regions in the truncated peptides, we produced a series of chimeric peptides combining the N-terminal portion of GLP-1 or Ex-4 and the C-terminal segment of the helix-promoting peptide α-conotoxin pl14a. The helicity and structures of the chimeric peptides were confirmed using circular dichroism and NMR, respectively. We found no direct correlation between the fractional helicity and potency in signaling via the cAMP pathway. Rather, the most important feature for efficient receptor binding and signaling was the C-terminal helical segment (residues 22-27) directing the binding of Phe(22) into a hydrophobic pocket on the GLP-1R.


  • Organizational Affiliation
    • From the Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 Queensland, Australia.

Macromolecule Content 

  • Total Structure Weight: 4.5 kDa 
  • Atom Count: 311 
  • Modeled Residue Count: 39 
  • Deposited Residue Count: 39 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Exendin-4, Alpha/kappa-conotoxin pl14a chimera39Heloderma suspectumConus planorbis
This entity is chimeric
Mutation(s): 0 
Membrane Entity: Yes 
UniProt
Find proteins for P26349 (Heloderma suspectum)
Explore P26349 
Go to UniProtKB:  P26349
Find proteins for Q0N4U8 (Conus planorbis)
Explore Q0N4U8 
Go to UniProtKB:  Q0N4U8
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupsQ0N4U8P26349
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 50 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with the lowest energy 

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2016-05-18
    Type: Initial release
  • Version 1.1: 2016-05-25
    Changes: Database references, Structure summary
  • Version 1.2: 2016-06-08
    Changes: Database references
  • Version 1.3: 2016-08-17
    Changes: Database references
  • Version 1.4: 2023-06-14
    Changes: Data collection, Database references, Other
  • Version 1.5: 2024-10-30
    Changes: Data collection, Database references, Structure summary